By Stephen Nellis / Friday, October 19th, 2012 / Features, Technology / Comments Off on The high-tech plumber: Sani-Tech West keeps big bio names flowing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
By Editorial Board / Friday, August 17th, 2012 / Editorials, Opinion / Comments Off on Editorial: Following-up on Congressional insider trades
In late July, our news pages carried an article about a series of potentially favorable stock trades in shares of Thousand Oaks-based Amgen that may have benefited the wealthy wife of U.S. Sen. John Kerry. Disclosure of the trades, made in 2007 on behalf of a trust that benefits Teresa Heinz Kerry, would not have Read More →
By Henry Dubroff / Friday, July 27th, 2012 / Latest news / Comments Off on Newsom talks business recruitment at Amgen HQ
With about 100 Ventura County leaders gathered at the sprawling Amgen campus in Thousand Oaks, Lt. Gov. Gavin Newsom made a rare appearance in the Tri-Counties on July 27 to promote a new “Gold Team” effort to recruit businesses to California. Taking a stab at bi-partisanship, he appeared at the podium with Republican Assemblyman Jeff Read More →
By Julian Moore, Special to the Business Times, on July 27, 2012 In August, stock sales by members of Congress and thousands of federal employees will get new scrutiny under the STOCK Act, a law passed in April to combat insider trading among government officials. But a Business Times examination of the timing of the Read More →
By Staff Report / Thursday, July 26th, 2012 / Latest news / Comments Off on Amgen Q2 earnings up 8 percent
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-01-2012″ enddate=”26-07-2012″ width=”300″ height=”245″] Amgen’s earnings beat market expectations in the second quarter and rose 8.2 percent, the Thousand Oaks-based biotech giant said in a July 26 report. The company reported a profit of $1.27 billion, or $1.61 a share, up from $1.17 billion, or $1.25 a share, a year Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks-based Amgen is set to argue a case before the U.S. Supreme Court that could make it harder for shareholders to band together and sue publicly traded companies over public comments made by top officials. The court agreed to hear a stock-fraud case this fall between Amgen and Connecticut Retirement Plans and Trust Funds, Read More →